Priscilla Arlene Hollander MD
Diabetes, Lipid Metabolism
Endocrinologist, Baylor Endocrine Center
Join to view full profile
3600 Gaston AveSuite 656Dallas, TX 75246
Phone+1 214-820-3466
Fax+1 214-820-3468
Dr. Hollander is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1980
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1974 - 1977
Harvard Medical SchoolClass of 1974
Certifications & Licensure
TX State Medical License 1977 - 2027
MN State Medical License 1980 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2016-2017
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
Clinical Trials
- A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
- Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- Lack of Association of Emotional Distress With Insulin Initiation in the GRADE Randomized Diabetes Comparative Effectiveness Trial.Caroline A Presley, Nicole M Butera, Heidi Krause-Steinrauf, Cyrus V Desouza, Priscilla A Hollander
The Science of Diabetes Self-Management and Care. 2025-08-01 - 14 citationsGlucose-Lowering Medications, Glycemia, and Cognitive Outcomes: The GRADE Randomized Clinical Trial.José A Luchsinger, Samuel P Rosin, Erin J Kazemi, Naji Younes, Colleen E Suratt
JAMA Internal Medicine. 2025-07-01 - 1 citationsImmunogenicity, Efficacy, and Safety of Biosimilar Insulin Glargine (Gan & Lee Glargine) Compared With Originator Insulin Glargine (Lantus) in Patients With Type 1 Dia...Elena A Christofides, Andrzej Stankiewicz, Douglas Denham, Diego Bellido, Edward Franek
Endocrine Practice. 2024-09-01
Press Mentions
SGLT2 Inhibitor Adds to Weight Loss with PhentermineJune 16th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: